Return of chloroquine antimalarial efficacy in Malawi MK Laufer, PC Thesing, ND Eddington, R Masonga, FK Dzinjalamala, ... New England Journal of Medicine 355 (19), 1959-1966, 2006 | 525 | 2006 |
School-age children are a reservoir of malaria infection in Malawi JA Walldorf, LM Cohee, JE Coalson, A Bauleni, K Nkanaunena, ... PloS one 10 (7), e0134061, 2015 | 242 | 2015 |
Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites MK Laufer, S Takala-Harrison, FK Dzinjalamala, OC Stine, TE Taylor, ... The Journal of infectious diseases 202 (5), 801-808, 2010 | 186 | 2010 |
Dengue-related deaths in Puerto Rico, 1992–1996: diagnosis and clinical alarm signals JG Rigau-Pérez, MK Laufer Clinical infectious diseases 42 (9), 1241-1246, 2006 | 159 | 2006 |
Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi MK Laufer, JJG van Oosterhout, PC Thesing, F Thumba, EE Zijlstra, ... The Journal of infectious diseases 193 (6), 872-878, 2006 | 142 | 2006 |
Antimalarial drug resistance in Africa: key lessons for the future S Takala‐Harrison, MK Laufer Annals of the New York Academy of Sciences 1342 (1), 62-67, 2015 | 131 | 2015 |
Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data AEP Frosch, M Venkatesan, MK Laufer Malaria Journal 10, 1-10, 2011 | 119 | 2011 |
Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection: a randomized trial RV Barnabas, ER Brown, A Bershteyn, HC Stankiewicz Karita, ... Annals of internal medicine 174 (3), 344-352, 2021 | 114 | 2021 |
Return of Widespread Chloroquine-Sensitive Plasmodium falciparum to Malawi AEP Frosch, MK Laufer, DP Mathanga, S Takala-Harrison, J Skarbinski, ... The Journal of infectious diseases 210 (7), 1110-1114, 2014 | 103 | 2014 |
Malaria control in Malawi: current status and directions for the future DP Mathanga, ED Walker, ML Wilson, D Ali, TE Taylor, MK Laufer Acta tropica 121 (3), 212-217, 2012 | 98 | 2012 |
Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations MA Travassos, MK Laufer Pediatric research 65 (7), 64-70, 2009 | 98 | 2009 |
Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses LM Cohee, C Opondo, SE Clarke, KE Halliday, J Cano, AG Shipper, ... The Lancet Global Health 8 (12), e1499-e1511, 2020 | 96 | 2020 |
Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies MK Laufer, CV Plowe Drug Resistance Updates 7 (4-5), 279-288, 2004 | 95 | 2004 |
Monitoring and deterring drug-resistant malaria in the era of combination therapy MK Laufer, AA Djimdé, CV Plowe Defining and Defeating the Intolerable Burden of Malaria III: Progress and …, 2007 | 86 | 2007 |
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment LM Cohee, L Kalilani-Phiri, S Boudova, S Joshi, R Mukadam, KB Seydel, ... Malaria Journal 13, 1-9, 2014 | 85 | 2014 |
A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV JJG van Oosterhout, MK Laufer, SM Graham, F Thumba, MA Perez, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (5), 626-631, 2005 | 85 | 2005 |
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs RN Price, G Dorsey, EA Ashley, KI Barnes, JK Baird, U d'Alessandro, ... Malaria Journal 6, 1-9, 2007 | 76 | 2007 |
High prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: patterns and predictors of risk from a cross … JE Coalson, JA Walldorf, LM Cohee, MD Ismail, D Mathanga, RJ Cordy, ... Malaria journal 15, 1-17, 2016 | 75 | 2016 |
The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia S Mwanza, S Joshi, M Nambozi, J Chileshe, P Malunga, JBB Kabuya, ... Malaria journal 15, 1-6, 2016 | 74 | 2016 |
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential KA Moser, EF Drábek, A Dwivedi, EM Stucke, J Crabtree, A Dara, Z Shah, ... genome medicine 12, 1-17, 2020 | 73 | 2020 |